| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 32.634 | 48.924 | 48.615 | 47.365 | 38.471 | 37.554 | 39.654 | 44.676 | 64.570 |
| Total Income - EUR | - | 32.634 | 48.924 | 48.615 | 47.365 | 38.498 | 37.561 | 39.655 | 44.676 | 64.570 |
| Total Expenses - EUR | - | 4.738 | 7.849 | 6.895 | 8.217 | 11.189 | 9.468 | 12.775 | 10.939 | 15.403 |
| Gross Profit/Loss - EUR | - | 27.896 | 41.075 | 41.720 | 39.148 | 27.310 | 28.093 | 26.880 | 33.737 | 49.167 |
| Net Profit/Loss - EUR | - | 27.243 | 40.586 | 41.234 | 38.674 | 26.925 | 27.717 | 26.484 | 33.290 | 48.125 |
| Employees | - | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Kodamamed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 633 | 475 | 363 | 1.229 | 991 | 241 | 0 | 855 | 442 |
| Current Assets | - | 27.706 | 42.103 | 44.326 | 45.367 | 35.496 | 29.082 | 28.266 | 41.841 | 121.038 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 334 | 325 | 328 | 1.513 | 87 | 85 | 20.905 | 5.022 | 31.819 |
| Cash | - | 27.372 | 41.778 | 43.998 | 43.854 | 35.409 | 28.997 | 7.361 | 36.819 | 89.219 |
| Shareholders Funds | - | 27.288 | 40.749 | 42.984 | 42.705 | 30.881 | 27.730 | 26.497 | 38.950 | 48.174 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 1.051 | 1.829 | 1.705 | 3.891 | 5.606 | 1.593 | 1.769 | 3.746 | 73.306 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7311 - 7311" | |||||||||
| CAEN Financial Year |
7311
|
|||||||||
Comments - Kodamamed Srl